A First-In-Human Study of Single and Multiple Ascending Doses of Oral SUL-238 in Healthy Subjects

Clinical trial NCT06277492 · COMPLETED

Trial details

NCT number: NCT06277492
Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-02-19
Primary completion: 2025-07-11
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.